Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News Complete Archive »

Alphatec Spine Announces Retirement of James R. Glynn From Its Board of Directors; Donald A. Williams Appointed Audit Committee Chairman BY EDITOR, OCTOBER 29, 2015

Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced that James R. Glynn is retiring as a member of the board of directors and Audit Committee Chairman, effective November 2, 2015. Alphatec Spine's board of directors has appointed Donald A. Williams, an independent director of Alphatec's board of directors and current member of the Audit Committee, as the Chairman of the Audit Committee, effective November 2, 2015.

Mr. Williams joined the board of directors in May 2015 and previously was a Partner at Ernst & Young for eighteen years and a Partner with Grant Thornton, LLP for the last seven years. He has served as the lead partner on multiple initial public offerings, secondary offerings, private and public debt financings, as well as numerous mergers and acquisitions.

"We would like to thank Jim for his dedicated service and many contributions to Alphatec over the past eight years," said Jim Corbett, President and Chief Executive Officer of Alphatec Spine. "We appreciate his counsel and leadership during his tenure and wish him all the best in the future. Looking forward, we are very pleased to have Don serve as Chairman of the Audit Committee. Don's deep financial experience and strong business acumen has been a valuable asset to the board this year. We look forward to Don's guidance and operational expertise in his newly expanded role as we continue to execute the pillars of our strategy and build momentum for the future."

Further information regarding the Company's appointment of Donald A. Williams to its board of directors is set forth in a Current Reports on Form 8-K that the Company is expecting to file with the U.S. Securities and Exchange Commission (SEC) on November 2, 2015 and will be available on both the SEC's website at www.sec.gov and the Company's website at www.alphatecspine.com.

About Alphatec Spine
Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is a global medical device company that designs, develops, manufactures and markets spinal fusion technology products and solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities and trauma. The Company's mission is to improve lives by delivering advancements in spinal fusion technologies. The Company and its affiliates market products in the U.S. and internationally via a direct sales force and independent distributors.

Additional information can be found at www.alphatecspine.com.

Email this to a colleague: